← FDA DRUG APPROVALS

FDA ANDA · ANDA064033

CEFAZOLIN SODIUM

Sponsor: GLAXOSMITHKLINE

APPLICATION
ANDA064033
TYPE
ANDA
ORIGINAL APPROVAL
1993-10-31
LATEST ACTION
2005-01-28
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

CEFAZOLIN SODIUMDiscontinued
CEFAZOLIN SODIUM EQ 1GM BASE/VIAL · INJECTABLE · INJECTION

Approval history

2005-01-28Labeling · Supplement 7AP
2002-07-31Manufacturing (CMC) · Supplement 6AP
1998-05-28Manufacturing (CMC) · Supplement 3AP
1996-05-08Manufacturing (CMC) · Supplement 2AP
1993-10-31OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →